Bortezomib in combination with rituximab, dexamethasone, ifosfamide, cisplatin and etoposide chemoimmunotherapy in patients with relapsed and primary refractory diffuse large B-cell lymphoma. (Q53137051)
Jump to navigation
Jump to search
scientific article published in August 2012
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Bortezomib in combination with rituximab, dexamethasone, ifosfamide, cisplatin and etoposide chemoimmunotherapy in patients with relapsed and primary refractory diffuse large B-cell lymphoma. |
scientific article published in August 2012 |
Statements
Bortezomib in combination with rituximab, dexamethasone, ifosfamide, cisplatin and etoposide chemoimmunotherapy in patients with relapsed and primary refractory diffuse large B-cell lymphoma. (English)
Rebecca L Elstrom
Biree Andemariam
Peter Martin
Jia Ruan
Tsiporah B Shore
Morton Coleman
John P Leonard
Richard R Furman
1 August 2012
53
8
1469-1473
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference